• 1:中国心血管健康与疾病报告编写组

摘要(Abstract)：

近30年来，我国的医疗可及性和质量指数进步幅度举世瞩目，位列中等收入国家首位，多项心血管技术已处于世界领先或接近领先水平，我国在解决心血管病（CVD“）救治难”的问题上有了长足的进步。但由于我国居民不健康生活方式流行，有CVD危险因素的人群巨大，人口老龄化加速，我国CVD发病率和死亡率仍在升高，疾病负担下降的拐点尚未出现。在我国城乡居民疾病死亡构成比中，CVD占首位，2020年分别占农村、城市死因的48.00%和45.86%；每5例死亡中就有2例死于CVD。推算我国CVD现患人数3.3亿，其中脑卒中1 300万，冠心病1 139万，心力衰竭890万，肺原性心脏病500万，心房颤动487万，风湿性心脏病250万，先天性心脏病200万，外周动脉疾病4 530万，高血压2.45亿。中国进入了一个由高速发展向高质量发展转变的新阶段，中国的CVD防控事业也要由过去着眼于规模式增长转向更聚焦于战略层面和关键技术层面上的高质量发展，从而遏制CVD发病率和死亡率增长的趋势。

关键词(KeyWords)： 心血管病;流行病学;健康影响因素;危险因素;患病率;死亡率;社区防治;康复;基础研究;医疗器械研发

Abstract:

Keywords:

基金项目(Foundation):

作者(Author):

参考文献(References)：

• [1]GBD 2019 Tobacco Collaborators.Spatial,temporal,and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories,1990~2019:a systematic analysis from the Global Burden of Disease Study 2019[J].Lancet,2021,397(10292):2337-2360.DOI:10.1016/S0140-6736(21)01169-7.
• [2]He J,Gu DF,Wu XG,et al.Major causes of death among men and women in China[J].N Eng J Med,2005,353(11):1124-1134.DOI:10.1056/NEJMsa050467.
• [3]肖琳，南奕，邸新博，等.2018年中国15岁及以上人群吸烟现况及变化趋势研究[J].中华流行病学杂志，2022,43(6):811-817.DOI:10.3760/cma.j.cn112338-20211130-00934.
• [4]Zeng XY,Di XB,Liu SW,et al.Smoking behavior among secondary school students-China,2021[J].China CDC Wkly,2022,4(21):441-447.DOI:10.46234/ccdcw2022.099.
• [5]黄亚阳，邸新博，南奕，等.2010年与2018年中国15岁及以上非现在吸烟人群二手烟暴露情况及影响因素分析[J].中华流行病学杂志，2022,43(6):824-829.DOI:10.3760/cma.j.cn112338-20211130-00930.
• [6]Xiao L,Yin X,Di XB,et al.Awareness and prevalence of e-cigarette use among Chinese adults:policy implications[J].Tob Control,2022,31(4):498-504.DOI:10.1136/tobaccocontrol-2020-056114.
• [7]Liu Z,Li YH,Cui ZY,et al.Prevalence of tobacco dependence and associated factors in China:findings from nationwide China Health Literacy Survey during 2018-19[J].Lancet Reg Health West Pac,2022,24:100464.DOI:10.1016/j.lanwpc.2022.100464.
• [8]Han YT,Hu YZ,Li LM,et al.Lifestyle,cardiometabolic disease,and multimorbidity in a prospective Chinese study[J].Eur Heart J,2021,42(34):3374-3384.DOI:10.1093/eurheartj/ehab413.
• [9]Huang LN,Wang ZH,Wang HJ,et al.Nutrition transition and related health challenges over decades in China[J].Eur J Clin Nutr,2021,75(2):247-252.DOI:10.1038/s41430-020-0674-8.
• [10]中国营养学会.中国居民膳食指南科学研究报告2021[M].北京：人民卫生出版社，2022.
• [11]国家卫生健康委疾病预防控制局.中国居民营养与慢性病报告（2020年）[M].北京：人民卫生出版社，2022.
• [12]Fardet A,Aubrun K,Rock E.Nutrition transition and chronic diseases in China (1990-2019):industrially processed and animal calories rather than nutrients and total calories as potential determinants of the health impact[J].Public Health Nutr,2021,24(16):5561-5575.DOI:10.1017/S1368980021003311.
• [13]Wang YF,Feng L,Zeng G,et al.Effects of cuisine-based Chinese heart-healthy diet in lowering blood pressure among adults in China:multicenter,single-blind,randomized,parallel controlled feeding trial[J].Circulation,2022,146(4):303-315.DOI:10.1161/CIRCULATIONAHA.122.059045.
• [14]Li KC,Huang LP,Tian MY,et al.Cost-effectiveness of a household salt substitution intervention:findings from20 995 participants of the Salt Substitute and Stroke Study[J].Circulation,2022,145(20):1534-1541.DOI:10.1161/CIRCULATIONAHA.122.059573.
• [15]Fan X,Cao ZB.Physical activity among Chinese schoolaged children:national prevalence estimates from the 2016Physical Activity and Fitness in China-The Youth Study[J].J Sport Health Sci,2017,6(4):388-394.DOI:10.1016/j.jshs.2017.09.006.
• [16]Zhu Z,Tang Y,Zhuang J,et al.Physical activity,screen viewing time,and overweight/obesity among Chinese children and adolescents:an update from the 2017 Physical Activity and Fitness in China-The Youth Study[J].BMC Public Health,2019,19(1):197.DOI:10.1186/s12889-019-6515-9.
• [17]Li C,Wang LM,Zhang X,et al.Leisure-time physical activity among Chinese adults-China,2015[J].China CDC Wkly,2020,2(35):671-677.DOI:10.46234/ccdcw2020.187.
• [18]Strain T,Brage S,Sharp SJ,et al.Use of the prevented fraction for the population to determine deaths averted by existing prevalence of physical activity:a descriptive study[J].Lancet Glob Health,2020,8(7):e920-e930.DOI:10.1016/S2214-109X(20)30211-4.
• [19]Bennett DA,Du H,Clarke R,et al.Association of physical activity with risk of major cardiovascular diseases in Chinese men and women[J].JAMA Cardiol,2017,2(12):1349-1358.DOI:10.1001/jamacardio.2017.4069.
• [20]Du HD,Bennett D,Li LM,et al.Physical activity and sedentary leisure time and their associations with BMI,waist circumference,and percentage body fat in 0.5 million adults:the China Kadoorie Biobank study[J].Am J Clin Nutr,2013,97(3):487-496.DOI:10.3945/ajcn.112.046854.
• [21]赵丽云，丁钢强，赵文华.2015-2017年中国居民营养与健康状况监测报告[M].北京：人民卫生出版社，2022.
• [22]Wang YF,Zhao L,Gao LW,et al.Health policy and public health implications of obesity in China[J].Lancet Diabetes Endocrinol,2021,9(7):446-461.DOI:10.1016/S2213-8587(21)00118-2.
• [23]国家卫生健康委疾病预防控制局.中国居民营养与慢性病状况报告（2020年）[M].北京：人民卫生出版社，2022.
• [24]Global Burden Disease 2019.Global health data exchange[EB/OL].(2022-8-27)[2023-05-21].http：//ghdx.healthdata.org/gbd-resultstool.
• [25]Jiang CQ,Xu L,Zhang WS,et al.Adiposity and mortality in older Chinese:an 11-year follow-up of the Guangzhou Biobank Cohort Study[J].Sci Rep,2020,10(1):1924.DOI:10.1038/s41598-020-58633-z.
• [26]Jia GC,Shu XO,Liu Y,et al.Association of adult weight gain with major health outcomes among middle-aged Chinese persons with low body weight in early adulthood[J].JAMANetwork Open,2020,2(12):e1917371.DOI:10.1001/jamanetworkopen.2019.17371.
• [27]Ren YP,Yang H,Browning C,et al.Prevalence of depression in coronary heart disease in China:a systematic review and Meta analysis[J].Chin Med J (Engl),2014,127(16):2991-2998.
• [28]中华医学会，中华医学会杂志社，中华医学会全科医学分会，等.抑郁症基层诊疗指南（2021年）[J].中华全科医师杂志，2021,20(12):1249-1260.DOI:10.3760/cma.j.cn114798-20211020-00778.
• [29]Teo KK,Liu L,Chow CK,et al.Potentially modifiable risk factors associated with myocardial infarction in China:the INTERHEART China study[J].Heart,2009,95(22):1857-1864.DOI:10.1136/hrt.2008.155796.
• [30]Li ZZ,Li YY,Chen LZ,et al.Prevalence of depression in patients with hypertension:a systematic review and Metaanalysis[J].Medicine (Baltimore),2015,94(31):e1317.DOI:10.1097/MD.0000000000001317.
• [31]Li HB,Qian F,Hou CB,et al.Longitudinal changes in depressive symptoms and risks of cardiovascular disease and allcause mortality:a nationwide population-based cohort study[J].J Gerontol A Biol Sci Med Sci,2020,75(11):2200-2206.DOI:10.1093/gerona/glz228.
• [32]Liu N,Pan XF,Yu CQ,et al.Association of major depression with risk of ischemic heart disease in a mega-cohort of Chinese adults:the China Kadoorie Biobank study[J].J Am Heart Assoc,2016,5(12):e004687.DOI:10.1161/JAHA.116.004687.
• [33]Wang ZW,Chen Z,Zhang LF,et al.Status of hypertension in China:results from the China Hypertension Survey,2012-2015[J].Circulation,2018,137(22):2344-2356.DOI:10.1161/CIRCULATIONAHA.117.032380.
• [34]张梅，吴静，张笑，等.2018年中国成年居民高血压患病与控制状况研究[J].中华流行病学杂志，2021,42(10):1780-1789.DOI:10.3760/cma.j.cn112338-20210508-00379.
• [35]Sun NL,Jiang YN,Wang HY,et al.Survey on sodium and potassium intake in patients with hypertension in China[J].JClin Hypertens (Greenwich),2021,23(11):1957-1964.DOI:10.1111/jch.14355.
• [36]Neal B,Wu YF,Feng XX,et al.Effect of salt substitution on cardiovascular events and death[J].N Engl J Med,2021,385(12):1067-1077.DOI:10.1056/NEJMoa2105675.
• [37]Zhang WL,Zhang SY,Deng Y,et al.Trial of intensive bloodpressure control in older patients with hypertension[J].N Engl J Med,2021,385(14):1268-1279.DOI:10.1056/NEJMoa2111437.
• [38]Sun YX,Mu JJ,Wang DW,et al.A village doctor-led multifaceted intervention for blood pressure control in rural China:an open,cluster randomised trial[J].Lancet,2022,399(10339):1964-1975.DOI:10.1016/S0140-6736(22)00325-7.
• [39]尤莉莉，赵金红，陈新月，等.国家基本公共卫生服务项目实施十年的进展与成效[J].中国全科医学，2022,25(26):3209-3220.DOI:10.12114/j.issn.1007-9572.2022.0407.
• [40]Dong J,Dong H,Yan Y,et al.Prevalence of hypertension and hypertension phenotypes after three visits in Chinese urban children[J].J Hypertens,2021,40(7):1270-1277.DOI:10.1097/HJH.0000000000002977.
• [41]Liu K,Li C,Gong HB,et al.Prevalence and risk factors for hypertension in adolescents aged 12 to 17 years:a school-based study in China[J].Hypertension,2021,78(5):1577-1585.DOI:10.1161/HYPERTENSIONAHA.121.17300.
• [42]Ye XX,Yi Q,Shao J,et al.Trends in prevalence of hypertension and hypertension phenotypes among Chinese children and adolescents over two decades (1991-2015)[J].Front Cardiovasc Med,2021,8:627741.DOI:10.3389/fcvm.2021.627741.
• [43]Dong Y,Ma J,Song Y,et al.Secular trends in blood pressure and overweight and obesity in Chinese boys and girls aged 7 to 17years from 1995 to 2014[J].Hypertension,2018,72(2):298-305.DOI:10.1161/HYPERTENSIONAHA.118.11291.
• [44]Song PK,Man QQ,Li H,et al.Trends in lipids level and dyslipidemia among Chinese adults,2002-2015[J].Biomed Environ Sci,2019,32(8):559-570.DOI:10.3967/bes2019.074.
• [45]NCD Risk Factor Collaboration (NCD-RisC).Repositioning of the global epicentre of non-optimal cholesterol[J].Nature,2020,582(7810):73-77.DOI:10.1038/s41586-020-2338-1.
• [46]Ding WQ,Cheng H,Yan YK,et al.10-year trends in serum lipid levels and dyslipidemia among children and adolescents from several schools in Beijing,China[J].J Epidemiol,2016,26(12):637-645.DOI:10.2188/jea.JE20140252.
• [47]赵文华，张坚，由悦，等.中国18岁及以上人群血脂异常流行特点研究[J].中华预防医学杂志，2005,39(5):306-310.DOI:10.3760/j.issn.0253-9624.2005.05.004.
• [48]Pan L,Yang ZH,Wu Y,et al.The prevalence,awareness,treatment and control of dyslipidemia among adults in China[J].Atherosclerosis,2016,248:2-9.DOI:10.1016/j.atherosclerosis.2016.02.006.
• [49]戴璟，闵杰青，杨云娟.中国九省市成年人血脂异常流行特点研究[J].中华心血管病杂志，2018,46(2):114-118.DOI:10.3760/cma.j.issn.0253-3758.2018.02.009.
• [50]国家卫生计生委疾病预防控制局.中国居民营养与慢性病状况报告2015[M].北京：人民卫生出版社，2015.
• [51]中国高血压调查研究组.2012~2015年我国≥35岁人群血脂异常状况调查[J].中国循环杂志，2019,34(7):681-687.DOI:10.3969/j.issn.1000-3614.2019.07.011.
• [52]Lu Y,Zhang HB,Lu JP,et al.Prevalence of dyslipidemia and availability of lipid-lowering medications among primary health care settings in China[J].JAMA Netw Open,2021,4(9):e2127573.DOI:10.1001/jamanetworkopen.2021.27573.
• [53]Zhang M,Deng Q,Wang LH,et al.Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults:a nationally representative survey of 163,641adults[J].Int J Cardiol,2018,260:196-203.DOI:10.1016/j.ijcard.2017.12.069.
• [54]Opoku S,Gan Y,Fu WN,et al.Prevalence and risk factors for dyslipidemia among adults in rural and urban China:findings from the China National Stroke Screening and Prevention Project(CNSSPP)[J].BMC Public Health,2019,19(1):1500.DOI:10.1186/s12889-019-7827-5.
• [55]程红，肖培，侯冬青，等.2017年北京市6~16岁儿童青少年血脂异常流行特征及相关因素[J].中国循环杂志，2020,35(6):566-572.DOI:10.3969/j.issn.1000-3614.2020.06.008.
• [56]张梦妮，李茂婷，职心乐，等.1990-2019年中国动脉粥样硬化心血管病疾病负担变化及其危险因素分析[J].中华流行病学杂志，2021,41(10):1797-1803.DOI:10.3760/cma.j.cn112338-20201208-01390.
• [57]Xing YY,Liu J,Hao YC,et al.Prehospital statin use and low density lipoprotein cholesterol levels at admission in acute coronary syndrome patients with history of myocardial infarction or revascularization:findings from the Improving Care for Cardiovascular Disease in China (CCC) project[J].Am Heart J,2019,212:120-128.DOI:10.1016/j.ahj.2019.02.019.
• [58]邢月妍，刘静，刘军，等.75岁及以上老年急性冠状动脉综合征住院患者他汀使用现状及低密度脂蛋白胆固醇水平[J].中华心血管病杂志，2019,47(5):351-359.DOI:10.3760/cma.j.issn.0253-3758.2019.05.005.
• [59]Li SD,Liu ZG,Joseph P,et al.Modifiable risk factors associated with cardiovascular disease and mortality in China:a PURE substudy[J].Eur Heart J,2022,43(30):2852-2863.DOI:10.1093/eurheartj/ehac268.
• [60]曾雨虹，刘静，刘军，等.超高危ASCVD患者的界定标准对住院ACS患者降脂治疗需求的影响[J].中华心血管病杂志，2020,48(12):1039-1046.DOI:10.3760/cma.j.cn112148-20200710-00549.
• [61]Gong YJ,Li X,Ma X,et al.Lipid goal attainment in postacute coronary syndrome patients in China:results from the6-month real world dyslipidemia international studyⅡ[J].Clin Cardiol,2021,44(11):1575-1585.DOI:10.1002/clc.23725.
• [62]Li YZ,Teng D,Shi XG,et al.Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association:national cross sectional study[J].BMJ,2020,369:m997.DOI:10.1136/bmj.m997.
• [63]Wang CC,Xie ZL,Huang X,et al.Prevalence of cardiovascular disease risk factors in Chinese patients with type 2diabetes mellitus,2013-2018[J].Curr Med Res Opin,2022,38(3):345-354.DOI:10.1080/03007995.2021.2022382.
• [64]Gong QH,Zhang P,Wang JP,et al.Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance:30-year results of the Da Qing Diabetes Prevention Outcome Study[J].Lancet Diabetes Endocrinol,2019,7(6):452-461.DOI:10.1016/S2213-8587(19)30093-2.
• [65]Jiang X,Jiang H,Tao L,et al.The cost-effectiveness analysis of self efficacy-focused structured education program for patients with type 2 diabetes mellitus in mainland China setting[J].Front Public Health,2021,9:767123.DOI:10.3389/fpubh.2021.767123.
• [66]Zhang LX,Wang F,Wang L,et al.Prevalence of chronic kidney disease in China:a cross-sectional survey[J].Lancet,2012,379(9818):815-822.DOI:10.1016/S0140-6736(12)60033-6.
• [67]Jin HY,Zhou JY,Wu CK.Prevalence and health correlates of reduced kidney function among community-dwelling Chinese older adults:The China Health and Retirement Longitudinal Study[J].BMJ Open,2020,10(12):e042396.DOI:10.1136/bmjopen-2020-042396.
• [68]Zhang L,Zhao MH,Zuo L,et al.China kidney disease network (CK NET) 2016 annual data report[J].Kidney Int Suppl (2011),2020,10(2):e97-e185.DOI:10.1016/j.kisu.2020.09.001.
• [69]姚崇华，胡以松，翟凤英，等.我国2002年代谢综合征的流行情况[J].中国糖尿病杂志，2007,15(6):332-335.DOI:10.3321/j.issn.1006-6187.2007.06.005.
• [70]何宇纳，赵文华，赵丽云，等.中国2010-2012年成年人代谢综合征流行特征[J].中华流行病学杂志，2017,38(2):212-215.DOI:10.3760/cma.j.issn.0254-6450.2017.02.015.
• [71]何宇纳，赵文华，赵丽云.2010-2012年中国10~17岁儿童青少年代谢综合征流行情况[J].中华预防医学杂志，2017,51(6):513-518.DOI:10.3760/cma.j.issn.0253-9624.2017.06.011.
• [72]Institute for Health Metrics and Evaluation (IHME).Global Burden of Disease Study 2019 (GBD 2019) results[EB/OL].(2021)[2023-05-21].https：//ghdx.healthdata.org/gbd-results-tool.
• [73]中华人民共和国生态环境部.2021中国生态环境状况公报[EB/OL].(2022-05-26)[2023-03-26].http：//www.gov.cn/xinwen/2022-05/28/5692799/files/349e930e68794f3287888d8dbe9b3ced.pdf.
• [74]Liu C,Yin P,Chen RJ,et al.Ambient carbon monoxide and cardiovascular mortality:a nationwide time-series analysis in272 cities in China[J].Lancet Planet Health,2018,2(1):e12-e18.DOI:10.1016/S2542-5196(17)30181-X.
• [75]Yin P,Chen RJ,Wang LJ,et al.Ambient ozone pollution and daily mortality:a nationwide study in 272 Chinese cities[J].Environ Health Perspect,2017,125(11):117006.DOI:10.1289/ehp1849.
• [76]Chen RJ,Yin P,Meng X,et al.Associations between ambient nitrogen dioxide and daily cause-specific mortality:evidence from 272 Chinese cities[J].Epidemiology,2018,29(4):482-489.DOI:10.1097/EDE.0000000000000829.
• [77]Wang LJ,Liu C,Meng X,et al.Associations between shortterm exposure to ambient sulfur dioxide and increased causespecific mortality in 272 Chinese cities[J].Environ Int,2018,117:33-39.DOI:10.1016/j.envint.2018.04.019.
• [78]Chen RJ,Yin P,Meng X,et al.Fine particulate air pollution and daily mortality.A nationwide analysis in 272 Chinese cities[J].Am J Respir Crit Care Med,2017,196(1):73-81.DOI:10.1164/rccm.201609-1862OC.
• [79]Sun Y,Zhang Y,Chen C,et al.Impact of heavy PM(2.5)pollution events on mortality in 250 Chinese counties[J].Environ Sci Technol,2022,56(12):8299-8307.DOI:10.1021/acs.est.1c07340.
• [80]Liang FC,Xiao QY,Huang KY,et al.The 17-y spatiotemporal trend of PM(2.5) and its mortality burden in China[J].Proc Natl Acad Sci U S A,2020,117(41):25601-25608.DOI:10.1073/pnas.1919641117.
• [81]Tang R,Zhao J,Liu YF,et al.Air quality and health co-benefits of China’s carbon dioxide emissions peaking before 2030[J].Nat Commun,2022,13(1):1008.DOI:10.1038/s41467-022-28672-3.
• [82]Yang JZ,Zhao Y,Cao J,et al.Co-benefits of carbon and pollution control policies on air quality and health till 2030 in China[J].Environ Int,2021,152:106482.DOI:10.1016/j.envint.2021.106482.
• [83]Li D,Xiao H,Ma S,et al.Health benefits of air quality improvement:Empirical research based on medical insurance reimbursement data[J].Front Public Health,2022,10:855457.DOI:10.3389/fpubh.2022.855457.
• [84]姜莹莹，齐力，毛凡，等.国家慢性病综合防控示范区多部门合作现状研究[J].中国卫生政策研究，2019,12(11):59-66.DOI:10.3969/j.issn.1674-2982.2019.11.011.
• [85]张微微，王丽娟.2013-2020年鞍山市立山区慢性病综合防控示范区建设成效评估[J].预防医学论坛，2022,28(2):81-84.
• [86]张晗，熊巨洋，管文博，等.慢性病管理效果分析：以国家慢性病综合防控示范区为例[J].中国医院，2019,23(1):15-17.DOI:10.19660/j.issn.1671-0592.2019.01.06.
• [87]Wang W,Liu YN,Liu JM,et al.Mortality and years of life lost of cardiovascular diseases in China,2005-2020:empirical evidence from national mortality surveillance system[J].Int J Cardiol,2021,340:105-112.DOI:10.1016/j.ijcard.2021.08.034.
• [88]国家卫生健康委员会.中国卫生健康统计年鉴2021[M].北京：中国协和医科大学出版社，2021.
• [89]国家卫生计生委统计信息中心.第五次国家卫生服务调查分析报告2013[M].北京：中国协和医科大学出版社，2016.
• [90]Li J,Li X,Wang Q,et al.ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study):a retrospective analysis of hospital data[J].Lancet,2015,385(9966):441-451.DOI:10.1016/S0140-6736(14)60921-1.
• [91]Xu HY,Yang YJ,Wang CS,et al.Association of hospitallevel differences in care with outcomes among patients with acute ST-segment elevation myocardial infarction in China[J].JAMANetw Open,2020,3(10):e2021677.DOI:10.1001/jamanetworkopen.2020.21677.
• [92]赵延延，杨进刚，许浩博，等.中国医院急性ST段抬高型心肌梗死医疗质量与住院死亡率的相关性分析[J].中国循环杂志，2019,34(5):437-443.DOI:10.3969/j.issn.1000-3614.2019.05.003.
• [93]Hao YC,Zhao D,Liu J,et al.Performance of management strategies with classⅠrecommendations among patients hospitalized with ST segment elevation myocardial infarction in China[J].JAMA Cardiol,2022,7(5):484-491.DOI:10.1001/jamacardio.2022.0117.
• [94]Hu MJ,Peng Y,Gao XJ,et al.Coronary intervention in STsegment elevation myocardial infarction patients with symptom onset>12 hours:data from China Acute Myocardial Infarction Registry[J].Angiology,2023,74(2):171-180.DOI:10.1177/00033197221098885.
• [95]Li X,Gu DC,Wang XQ,et al.Trends of coronary artery bypass grafting performance in a cohort of hospitals in China between 2013 and 2018[J].Circ Cardiovasc Qual Outcomes,2021,14(4):e007025.DOI:10.1161/CIRCOUTCOMES.120.007025.
• [96]Ma QF,Li R,Wang LJ,et al.Temporal trend and attributable risk factors of stroke burden in China,1990-2019:an analysis for the Global Burden of Disease Study 2019[J].Lancet Public Health,2021,6(12):e897-e906.DOI:10.1016/S2468-2667(21)00228-0.
• [97]Sun T,Chen SY,Wu K,et al.Trends in incidence and mortality of stroke in China from 1990 to 2019[J].Front Neurol,2021,12:759221.DOI:10.3389/fneur.2021.759221.
• [98]Gu HQ,Yang X,Wang CJ,et al.Clinical characteristics,management,and in-hospital outcomes in patients with stroke or transient ischemic attack in China[J].JAMANetw Open,2021,4(8):e2120745.DOI:10.1001/jamanetworkopen.2021.20745.
• [99]Ni WY,Kunz WG,Goyal M,et al.Quality of life and cost consequence of delays in endovascular treatment for acute ischemic stroke in China[J].Health Econ Rev,2022,12(1):4.DOI:10.1186/s13561-021-00352-w.
• [100]Cai ZL,Cai D,Wang RW,et al.Cost-effectiveness of CYP2C19 genotyping to guide antiplatelet therapy for acute minor stroke and high-risk transient ischemic attack[J].Sci Rep,2021,11(1):7383.DOI:10.1038/s41598-021-86824-9.
• [101]Shi SB,Tang YH,Zhao QY,et al.Prevalence and risk of atrial fibrillation in China:a national cross-sectional epidemiological study[J].Lancet Reg Health West Pac,2022,23:100439.DOI:10.1016/j.lanwpc.2022.100439.
• [102]胡大一，孙艺红，周自强，等.中国人非瓣膜性心房颤动脑卒中危险因素的病例-对照研究[J].中华内科杂志，2003,42(3):157-161.DOI:10.3760/j.issn.0578-1426.2003.03.004.
• [103]Chang SS,Dong JZ,Ma CS,et al.Current status and time trends of oral anticoagulation use among Chinese patients with nonvalvular atrial fibrillation:the Chinese Atrial Fibrillation Registry Study[J].Stroke,2016,47(7):1803-1810.DOI:10.1161/STROKEAHA.116.012988.
• [104]Bai Y,Liu XY,Liu Y,et al.Prevalence of recommended anticoagulation by guidelines preadmission and its impact on the incidence of acute myocardial infarction (AMI) and in-hospital outcomes after AMI in atrial fibrillation patients[J].J Thromb Thrombolysis,2022,54(1):91-96.DOI:10.1007/s11239-021-02622-0.
• [105]黄从新，张澍，马长生，等.中国经导管消融治疗心房颤动注册研究-2008[J].中华心律失常学杂志，2011,15(4):247-251.DOI:10.3760/cma.j.issn.1007-6638.2011.04.002.
• [106]Liu Y,Zhan XZ,Xue YM,et al.Incidence and outcomes of cerebrovascular events complicating catheter ablation for atrial fibrillation[J].Europace,2016,18(9):1357-1365.DOI:10.1093/europace/euv356.
• [107]Zhang JH,Zhou XH,Xing Q,et al.Epidemiological investigation of sudden cardiac death in multiethnic Xinjiang Uyghur autonomous region in Northwest